Home » Authors » Trista Morrison

Articles by Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Vasogen Brings In $20.3M To Fund Celacade, VP025 Programs

Nov. 10, 2006

By Trista Morrison

Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product

Nov. 9, 2006

By Trista Morrison

Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product

Nov. 9, 2006

By Trista Morrison

Celgene Raises $1B As Part Of Addition To S&P 500 Index

Nov. 7, 2006

By Trista Morrison

Celgene Raises $1B As Part Of Addition To S&P 500 Index

Nov. 7, 2006

By Trista Morrison

Exelixis' Stock Falls After XL999 Phase II Suspension

Nov. 3, 2006

By Trista Morrison

Exelixis' Stock Falls After XL999 Phase II Suspension

Nov. 3, 2006

By Trista Morrison

Critical Therapeutics Gets $20M, Bets On Zileuton CR

Nov. 2, 2006

By Trista Morrison

Critical Therapeutics Gets $20M, Bets On Zileuton CR

Nov. 2, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...